In Vitro Study of [18F]F-FAPI-74 Feasibility in Vulvar Cancer

Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18+
SponsorFondazione Policlinico Universitario Agostino Gemelli IRCCS

About this trial

This study aims to investigate the expression of FAP by phosphor imaging in invasive vulvar squamous cell carcinoma specimens. This in vitro study will include all consecutive tumour specimens stored both in optimal cutting temperature (OCT) compound and formalin-fixed paraffin-embedded (FFPE) from patients with a first diagnosis of vulvar squamous cell carcinoma who underwent surgery at Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.

Eligibility criteria

Qualifiers

Patients with histologically confirmed diagnosis of invasive vulvar cancer with squamous cell histotype, both from primary tumour site and excised metastatic LNs.

Availability of both FFPE and OCT stored samples from each primary tumour site and (when available) from the corresponding metastatic groin lymph nodes.

Samples stored in sufficient quantity not to be completely exhausted by their use for this study.

Optimal stored sample

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

90 Participants
are grouped into 1 trial group

Locations

1
Fondazione Policlinico Universitario Agostino Gemelli IRCCS00168, RomeRM, Italy

Sponsors and collaborators

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Lead sponsor